Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Y. Asao
Clinical Efficacy and Safety of Monthly Oral Ibandronate 100 Mg Versus Monthly Intravenous Ibandronate 1 Mg in Japanese Patients With Primary Osteoporosis
Osteoporosis International
Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Correction To: Effectiveness of Monthly Intravenous Ibandronate on the Low Responders to Oral Bisphosphonate: The MOVEMENT Study
Journal of Bone and Mineral Metabolism
Sports Medicine
Endocrinology
Orthopedics
Medicine
Metabolism
Diabetes
Long-Term Renal Safety Profile of Ibandronate 6 Mg Infused Over 15 Minutes
Bone
Endocrinology
Physiology
Histology
Metabolism
Diabetes
Ibandronate in the Treatment of Pediatric Osteoporosis
Bone Abstracts
Patient Satisfaction in Postmenopausal Women Treated With a Weekly Bisphosphonate Transitioned to Once-Monthly Ibandronate
Journal of Women's Health
Medicine
The Effect of Monthly Ibandronate on Bone Mineral Density and Bone Turnover Markers in Patients With Hemophilia a or B and Increased Risk for Fracture
Endocrine Abstracts
Erratum To: Efficacy and Safety of Olmesartan Medoxomil 40 Mg/Hydrochlorothiazide 12.5 Mg Combination Therapy Versus Olmesartan Medoxomil 40 Mg Monotherapy in Patients With Moderate to Severe Hypertension
Clinical Drug Investigation
Medicine
Pharmacology
Oral Weekly Ibandronate Prevents Bone Loss in Postmenopausal Women
Journal of Internal Medicine
Internal Medicine
Evidence of Sustained Vertebral and Nonvertebral Antifracture Efficacy With Ibandronate Therapy: A Systematic Review
Therapeutic Advances in Musculoskeletal Disease
Rheumatology
Orthopedics
Sports Medicine
Safety and Efficacy of Rapid (1,000 Mg in 1 Hr) Intravenous Iron Dextran for Treatment of Maternal Iron Deficient Anemia of Pregnancy
American Journal of Hematology
Hematology
